# Creative Essences Inc – FDA Inspection, Mar 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/creative-essences-inc/97d6c17a-776b-48e4-9183-f93e53bb566d
Source feed: FDA_Inspections

> FDA inspection 1264931 of Creative Essences Inc, March 25, 2025. Classification: Official Action Indicated (OAI). 11 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264931
- Company Name: Creative Essences Inc
- Inspection Date: 2025-03-25
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 11

## Related Documents

- [FDA Inspection 1128728 - 2020-09-04](https://www.keypedia.com/records/fda_inspections/creative-essences-inc/8b4d9e4f-ed01-473b-9bac-a62f8fd8e657)
- FDA Inspection 773393 - 2012-03-07

## Related Officers

- [Company Rep](https://www.keypedia.com/people/aranjeet-singh/7359f43e-0e36-4cdd-a77d-3371d8b44b99)
- [Investigator](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)
- [Issuing Officer](https://www.keypedia.com/people/thuy-tram-l-nguyen/b58f2445-728e-4f79-b7eb-4dfb7e982e25)

Company: https://www.keypedia.com/companies/creative-essences-inc/ad4207ce-5720-4c6b-ad8b-7b67087bd0d9

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
